Nedd4.2 is a regulator of ENac, a transporter of sodium involved in the regulation of salt retention by the kidney. The study address the consequence of a frequent genetic variation leading expected to impact the function of Nedd4 and in turn, the ability of kidneys to excrete salt intake. Our hypothesis is that the genetic variants of Nedd4.2 could constitute a genetic predisposition to (or protection against) salt-sensitive hypertension.
Subjects were submitted one week to a low sodium-high potassium diet, and then switch to a high sodium,-low potassium diet for two weeks. the last week, subject were taken a 20 MG daily dose of amiloride, a potassium sparing diuretic.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Enrollment
219
only arm of the trial
Difference in Blood Pressure among genotypes
24h AMBP will be measured weekly for the duration of study, an expected average of 3 weeks
Time frame: 24h AMBP will be measured weekly for the duration of study, an expected average of 3 weeks
Ambulatory Blood Pressure (AMBP)
24h AMBP was measured fourth : at the beginning of the study,at the end of the low sodium-high potassium diet, after one week under the high sodium-low potassium diet and at the end of amiloride treatment under high sodium-low potassium diet
Time frame: three weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.